Neuroprotective Effect of Chitosan Oligosaccharide on Hypoxic-Ischemic Brain Damage in Neonatal Rats
- 28 July 2017
- journal article
- research article
- Published by Springer Nature in Neurochemical Research
- Vol. 42 (11) , 3186-3198
Abstract
Neonatal hypoxic-ischemic brain damage (HIBD) is one of the leading causes of neonatal mortality and permanent neurological disability worldwide and the effective treatment strategies are not yet available. It has been demonstrated that Chitosan oligosaccharide (COS) exerts protective effect in vitro ischemic brain injury. However, no information is available on possible effects of COS on neonatal HIBD. To investigate the hypothesis of the potential neuroprotective effect of COS on the brain injury due to HIBD, 7-day-old Sprague–Dawley rats were treated with left carotid artery ligation followed by exposure to 8% oxygen (balanced with nitrogen) for 2.5 h at 37 °C. After COS treatment, the cerebral damage was measured by behavior tasks, 2,3,5-triphenyltetrazolium chloride(TTC), Hematoxyline-Eosin(HE), Nissl and Fluoro-Jade B(FJB)staining. In addition, the oxidative stress were assayed with ipsilateral hemisphere homogenates. Immunofluorescence staining were used to examine the activation of the astrocyte and microglia. Expression of inflammatory-related proteins were analyzed by western-blot analysis. In this study we found that administration of COS ameliorated early neurological reflex behavior, significantly reduce brain infarct volume and attenuated neuronal cell injury and degeneration. Furthermore, COS markedly decreased the level of MDA, lactic acid and increased SOD, GSH-Px and T-AOC. COS attenuated hypoxic-ischemic induced up-regulation of expressions of interleukin-1β (IL-1β), tumor necrosis factor alpha (TNF-α), meanwhile it dramatically increased the interleukin-10 (IL-10). These results suggest that COS exerts neuroprotection on hypoxic-ischemic brain damage in neonatal rats, it implies COS might be a potential therapeutic for the treatment of HIBD.Keywords
Funding Information
- The National Natural Science Foundation of China (81660261)
- the Ningxia Hui Autonomous Region science and technology support program (2015BAK45B01)
- the Ningxia Hui Autonomous Region thirteen five major science and technology Program (2016BZ07)
This publication has 59 references indexed in Scilit:
- Neonatal hypoxic ischemic encephalopathy: an update on disease pathogenesis and treatmentExpert Review of Neurotherapeutics, 2016
- Chitosan oligosaccharide affects antioxidant defense capacity and placental amino acids transport of sowsBMC Veterinary Research, 2016
- The challenge of understanding cerebral white matter injury in the premature infantNeuroscience, 2014
- Serial Examination of Serum IL‐8, IL‐10 and IL‐1Ra Levels is Significant in Neonatal Seizures Induced by Hypoxic–Ischaemic Encephalopathy1Scandinavian Journal of Immunology, 2012
- Perinatal Hypoxic‐Ischemic EncephalopathyBioMed Research International, 2010
- Chitosan Modification and Pharmaceutical/Biomedical ApplicationsMarine Drugs, 2010
- Inhibition of NADPH Oxidase is Neuroprotective after Ischemia—ReperfusionJournal of Cerebral Blood Flow & Metabolism, 2009
- Chemokine and Inflammatory Cell Response to Hypoxia-Ischemia in Immature RatsPediatric Research, 1999
- Role of Oxidants in Ischemic Brain DamageStroke, 1996
- Behavioral performance of rats following neonatal hypoxia-ischemia.Stroke, 1986